UBE2U,or "Ubiquitin-Conjugating Enzyme E2 U," is a protein that in humans is encoded by the UBE2U gene. This enzyme is a member of the ubiquitin-conjugating (E2) enzyme family, playing a crucial role in the ubiquitination pathway, a fundamental process for protein degradation and regulation within the cell.Ubiquitination is a process where ubiquitin, a small regulatory protein, is attached to substrates, typically signaling them for degradation via the proteasome or altering their cellular location, activity, or interactions. UBE2U functions as an E2 enzyme, which is responsible for the transfer of ubiquitin from the E1 activating enzyme to specific substrates, often with the assistance of an E3 ubiquitin ligase.The specific substrates and biological functions of UBE2U are still under research, but given the general importance of ubiquitination in cellular regulation, it is likely involved in multiple critical cellular processes. This can include cell cycle regulation, DNA repair, and response to stress or external stimuli.
UBE2U's role in ubiquitination suggests its involvement in various disease pathways, particularly those where protein degradation and regulation are disrupted, such as in cancer, neurodegenerative disorders, and inflammatory conditions. Abnormalities in ubiquitination processes are linked to the pathogenesis of these diseases, highlighting the significance of enzymes like UBE2U in maintaining cellular homeostasis.In summary, UBE2U is an important component of the ubiquitination pathway, with roles in various cellular processes and disease mechanisms. As such, it remains a subject of active research in the field of molecular biology and biochemistry.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor, MG132 can affect ubiquitin-proteasome pathways, potentially impacting UBE2U function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Another proteasome inhibitor, Bortezomib might indirectly influence UBE2U by affecting protein degradation pathways. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A specific inhibitor of the proteasome, Lactacystin can modulate ubiquitination processes, potentially affecting UBE2U. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
An inhibitor of ubiquitin-activating enzyme E1, PYR-41 might indirectly impact UBE2U activity in the ubiquitination pathway. | ||||||
DBeQ | 177355-84-9 | sc-499943 | 10 mg | $330.00 | 1 | |
Inhibits USP14, a deubiquitinating enzyme, potentially influencing ubiquitination pathways involving UBE2U. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates protein degradation pathways, might have indirect effects on UBE2U's activity. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
An immunomodulatory drug, can influence protein homeostasis and potentially UBE2U function. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
Similar to Thalidomide, affects protein degradation pathways, potentially impacting UBE2U. | ||||||